|
Volumn 18, Issue 17, 2010, Pages 6442-6450
|
Antiviral agents 2. Synthesis of trimeric naphthoquinone analogues of conocurvone and their antiviral evaluation against HIV
|
Author keywords
Anti HIV activity; Conocurvone; HIV integrase inhibition; Naphthoquinone trimers
|
Indexed keywords
2 BROMO 3 (4' TOLUENESULFONYLOXY) 6,7 DIMETHOXY 1,4 NAPHTHOQUINONE;
2 BROMO 3 HYDROXY 6,7 DIMETHOXY 1,4 NAPHTHOQUINONE;
2 HYDROXY 3 (3' (2'' HYDROXY 5'' METHOXY 1'',4'' DIOXO 1'', 4'' DIHYDRONAPHTHALENE 3'' YL) 1',4' DIOXO 1'',4'' DIHYDRONAPHTHALENE 2' YL) 5 METHOXY 1,4 NAPHTHOQUINONE;
2 HYDROXY 3 (3' (2'' HYDROXY 6'',7''DIMETHOXY 1'',4'' DIOXODIHYDRONAPHTHALENE 3'' YL) 1',4' DIOXO 6',7' DIMETHOXY NAPHTHALENE 2' YL) 6,7 DIMETHOXY 1,4 NAPHTHOQUINONE;
2 HYDROXY 3 (3' (2'' HYDROXY 7'' METHOXY 1'',4'' DIOXO 1'',4'' DIOXO 1'',4'' DIHYDRONAPHTHALENE 3'' YL) 1',4' DIOXO 1',4' NAPHTHALENE 2' YL) 1,4 DIOXO 1,4 DIHYDRONAPHTHALENE;
2 HYDROXY 3 (3' (2''HYDROXY 6'',7'' DIMETHOXY 1'',4'' DIOXO 1'',4'' DIHYDRONAPHTHALENE 3'' YL) 1',4' DIOXO 1',4' DIHYDRONAPHTHALENE 2' YL) 6,7 DIMETHOXY 1,4 NAPHTHOQUINONE;
2 HYDROXY 3 (3' 3' (2'' HYDROXY 1'',4'' DIOXO 1'',4'' DIHYDRONAPHTHALENE 3''YL) 1',4' DIOXO 1',4' DIHYDRONAPHTHALENE 2' YL) 1,4 NAPHTHOQUINONE;
2 HYDROXY 5 METHOXY 1,4 NAPHTHOQUINONE;
2 HYDROXY 6,7 DIMETHOXY 1,4 NAPHTHOQUINONE;
2 HYDROXY 7 METHOXY 1,4 NAPHTHOQUINONE;
2,3 DICHLORO 6 ISOPROPYLOXY 1,4 NAPHTHOQUINONE;
8 (8' BROMO 3',3' DIMETHYL 7',1'' DIOXO 1',2',7',1'' TETRAHYDRO 30H NAPHTHO[2,1 B]PYRAN 9' YL) 9 HYDROXY 3,3 DIMETHYL 3H NAPHTHO[2,1 B]PYRAN 7,10 DIONE;
8 BROMO 3,3 DIMETHYL 9 (4 TOLUENESULFONYLOXY) 1,2 DIHYDRO 3H NAPHTHO[2,1 B]PYRAN 7,10 DIONE;
8 BROMO 9 HYDROXY 3,3 DIMETHYL 1,2 DIHYDRO 3H NAPHTHO[2,1 B]PYRAN 7,10 DIONE;
9 HYDROXY 8 (3' (9'' HYDROXY 3'',3'' DIMETHYL 7'',1''' DIOXO 7'',1''' DIHYDRO 3''H NAPHTHO[2,1 B]PYRAN 8'' YL) 1,4' DIOXO 6' ISOPROPYLOXY 1',4' DIHYDRONAPHTHALEN 2' YL) 3,3 DIMETHYL 3H NAPHTHO[2,1 B]PYRAN 7,10 DIONE;
9 HYDROXY 8 (4' (9'' HYDROXY 3'',3'' DIMETHYL 7'',1''' DIOXO 7'',1'''DIHYDRO 3''H NAPHTHO[2,1 B]PYRAN 8'' YL) 1 BENZYL 1H PYRROLE 2,5 DIONE) 3,3 DIMETHYL 3H NAPHTHO[2,1 B]PYRAN 7,10 DIONE;
9 HYDROXY 8 (8' (9'' HYDROXY 3'',3'' DIMETHYL 7'',1''' DIOXO 7'',1''' DIHYDRO 3''H NAPHTHO[2,1 B]PYRAN 8'' YL) 3',3' DIMETHYL 7',1'' DIOXO ,7',1'' DIHYDRO 3'H NAPHTHO[2,1 B]PYRAN 9' YL) 3,3 DIEMTHYL 3H NAPHTHO[2,1 B]PYRAN 7,10 DIONE;
9 HYDROXY 8 (8' (9'' HYDROXY 3'',3'' DIMETHYL 7'',1'''DIOXO 7'',1'''DIHYDRO 3''H NAPHTHO[2,1 B]PYRAN 8'' YL) 3',3' DIMETHYL 7',1'' DIOXO 1',2',7',1'' TETRAHYDRO 30H NAPHTHO[2,1 B]PYRAN 9' YL) 3,3 DIMETHYL 3H NAPHTHO[2,1 B]PYRAN 7,10 DIONE;
ANTIVIRUS AGENT;
CONOCURVONE DERIVATIVE;
MALEIMIDE DERIVATIVE;
QUINONE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANTIVIRAL ACTIVITY;
ARTICLE;
DRUG SCREENING;
DRUG SYNTHESIS;
ELECTROPHILICITY;
ENZYME ACTIVITY;
HUMAN IMMUNODEFICIENCY VIRUS 1;
IN VITRO STUDY;
MAXIMUM PLASMA CONCENTRATION;
NONHUMAN;
RAT;
TIME TO MAXIMUM PLASMA CONCENTRATION;
ANIMALS;
ANTI-HIV AGENTS;
HIV INTEGRASE;
HIV INTEGRASE INHIBITORS;
HIV-1;
HUMANS;
NAPHTHOQUINONES;
RATS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 77955981248
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2010.06.105 Document Type: Article |
Times cited : (25)
|
References (23)
|